The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients
- 16 December 2004
- journal article
- Published by Springer Nature in Leukemia
- Vol. 19 (3) , 484-485
- https://doi.org/10.1038/sj.leu.2403621
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Immunogenicity of Bcl-2 in patients with cancerBlood, 2005
- Prognostic Significance of a Short Sequence Insertion in the MCL-1 Promoter in Chronic Lymphocytic LeukemiaJNCI Journal of the National Cancer Institute, 2004
- Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein familyLeukemia, 2003
- Myeloid cell factor–1 is a critical survival factor for multiple myelomaBlood, 2002
- Poor correspondence between predicted and experimental binding of peptides to class I MHC moleculesTissue Antigens, 2000
- Mcl-1 in Transgenic Mice Promotes Survival in a Spectrum of Hematopoietic Cell Types and Immortalization in the Myeloid LineageBlood, 1998
- Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumorsBreast Cancer Research and Treatment, 1998